唑来膦酸在一例多发性骨髓瘤患者中的应用
摘要
1病例介绍
患者女,80岁。因"腰背疼痛1年,加重1个月"入院。1年前患者因腰痛于当地医院行骨密度检查示"重度骨质疏松";胸腰椎X线片提示多发椎体压缩骨折。行"椎体成形术",术后疼痛完全缓解,生活自理。出院后患者间断予补钙及阿仑膦酸钠抗骨质疏松治疗。
出处
《华西医学》
CAS
2011年第7期1119-1119,共1页
West China Medical Journal
参考文献9
-
1Zeimer H, Firkin F, Grill V, et al. A ssessm en t of cellular expression of parathyroid hormone-related protein mRNA and protein in multiple myeloma[J]. J Pathol, 2000, 192 (3): 336-341.
-
2Major P, Lortholary A, Hon J, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcernia of malignancy: a pooled analysis of two randomized, controlled clinical trials[J].J Clin Oncol, 2001, 19(2): 558-567.
-
3Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases inpatients with breast cancer or osteolytic lesions of multiple myeloma: a phaseⅢ, double-blind, comparative trial [J]. Cancer J, 2001, 7(5) : 377-387.
-
4Rosen LS, Gordon D, Kaminski M, etal. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double- blind, multicenter, comparative trial[J]. Cancer, 2003, 98(8): 1735-1744.
-
5罗利琼,张丽娟,冯刚.唑来膦酸治疗多发性骨髓瘤骨痛的疗效[J].实用医学杂志,2010,26(17):3223-3224. 被引量:11
-
6Santini D, Fratto ME, Vincenzi B, et al. Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities[J]. BioDrugs, 2004, 18 (4) : 269-278.
-
7Heidenreich A, Ohlmann CH. Ibandronate its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease [J ]. Expert Rev Anticancer Ther, 2004, 4(6): 991-1005.
-
8Ramaswamy B, Shapiro CL. Bisphosphonates in the prevention and treatment of bone metastases [J].Oncology (Huntingt), 2003, 17(9): 1261-1270.
-
9金高娃,那仁图雅.唑来膦酸和帕米膦酸二钠治疗肿瘤骨转移性骨痛的比较研究[J].内蒙古医学杂志,2010,42(2):219-220. 被引量:4
二级参考文献13
-
1白海涛,王椿.双膦酸盐类药物治疗多发性骨髓瘤[J].世界临床药物,2005,26(6):364-367. 被引量:2
-
2王焰,沈志祥.多发性骨髓瘤骨病研究进展[J].上海医学,2007,30(3):214-216. 被引量:6
-
3Rosen I, Gordon D, Tchekmedyian S, et al. Zoledronic acid vet - SHS placebo in the trreatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase Ⅲ, double - blind, randomized trial - the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group[J]. J Clin Oncol, 2003, 21 (16):3 150-3 157.
-
4Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a Phase Ⅲ, double- blind, comparative trial [J].Cancer, 2001, 7 (5):377 - 387.
-
5Lee S, Rosen. Long - term efficacy and s', ffety of zoledronic acid compared with pamidronate disodium in the treatment Of skeletal complications in patients with advanced multiple myeloma or breast carcinoma[J]. Cancer, 2003, 98(8) : 1 735 - 1 744.
-
6Kyle R A, Rajkumar S V. Multiple Myeloma [J]. N Engl J Med, 2004,351(18) : 1860-1873.
-
7Tassone P, Forciniti S, Galea E, et al. Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines [J]. Leukemia, 2000,14 (5) : 841.
-
8Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronie acid [J]. J Pharmacol Exp Ther, 2002,302 ( 3 ) : 1055.
-
9Kunzmann V, Bauer E, Feurle J, et al. Stimulation of gammadeha T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma [J]. Blood, 2000, 96(2) :384.
-
10Barille S, Akhoundi C, Collette M, et al. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of pro MMP-2, and induction of MMP-1 by myeloma cells [J]. Blood, 1997,90(4) : 1649.
共引文献13
-
1石晶,付凌雨,刘云鹏,金波.唑来膦酸和帕米膦酸二钠治疗骨转移癌疼痛疗效比较的Meta分析[J].中华临床医师杂志(电子版),2011,5(17):5051-5056. 被引量:8
-
2林佳苗,钱冬女,夏哲林.二膦酸盐类药物的临床应用[J].医药导报,2010,29(12):1599-1602. 被引量:3
-
3田亚琼,张磊,刘树业.校正血钙对多发性骨髓瘤患者Durine-Salmon分期及肾功能的影响[J].实用医学杂志,2011,27(20):3776-3779. 被引量:1
-
4谢淑娟,占柳,潘卫红.唑来膦酸对颌骨骨质的不良反应及相关性研究进展[J].现代口腔医学杂志,2011,25(6):460-462. 被引量:1
-
5谢淑娟,占柳,潘卫红.唑来膦酸对颌骨骨质的影响及相关性研究进展[J].华中科技大学学报(医学版),2012,41(1):122-126. 被引量:8
-
6戚宝和,贾佳,徐锁平.HPLC法测定唑来膦酸含量及有关物质[J].中国当代医药,2011,18(36):46-47.
-
7吕青,郭梅香.多发性骨髓瘤诊断相关问题探讨(附68例报告)[J].中国民族民间医药,2012,21(11):9-9.
-
8吴平利.唑来膦酸联合化疗治疗晚期非小细胞肺癌骨转移的临床观察[J].中国医学创新,2012,9(26):100-101. 被引量:8
-
9赵建刚,尚官敏,董良,李海金,段广亮,李朝阳.大剂量帕米膦酸二钠治疗肿瘤骨转移疗效观察[J].中国药物与临床,2014,14(2):261-263. 被引量:3
-
10邸平,潘玉玲,王成彬.鉴别诊断多发性骨髓瘤实验方法新进展[J].医学综述,2014,20(6):1012-1014. 被引量:5
-
1郑勇,唐大伟,胡宏伟.多发性骨髓瘤1例误诊分析[J].中医正骨,2001,13(9).
-
2高琦珂.经皮椎体成形术治疗椎体压缩骨折及病变[J].实用医技杂志,2009,16(12):1003-1004. 被引量:2
-
3杨智慧.隐匿性肺癌的临床探讨[J].现代医药卫生,2008,24(3):389-390. 被引量:1
-
4高辉,陈志龙.椎管内肿瘤误诊为腰椎间盘突出症7例报告[J].中医正骨,2004,16(5):49-49.
-
5孔飞飞,张松黎,谭兴起,郭良君,王琴.静脉滴注骨瓜提取物注射液致严重过敏反应1例[J].中国药学杂志,2012,47(15):1207-1207. 被引量:6
-
6崔建和,崔芹,谭维琴,李天智,吴曼青.恶性肿瘤患者全身骨显像与骨密度检查的临床研究分析[J].中国骨质疏松杂志,2008,14(2):123-125. 被引量:5
-
7杨光平(编译).乳腺癌患者应注意补钙[J].家庭医学(上半月),2008(10):31-31.
-
8补钙可预防结肠癌[J].家庭医药(就医选药),2002(7):20-20.
-
9孟双全,朱贤友,王大鹏,王清义.PVP在椎体肿瘤及椎体压缩骨折中的临床应用[J].中医正骨,2005,17(2):34-35. 被引量:1
-
10高丽群.肝脏原发性非霍奇金淋巴瘤一例误诊[J].临床误诊误治,2009,22(4):89-89. 被引量:2